Browse > Article

Changes in Reproductive Function and White Blood Cell Proliferation Induced in Mice by Injection of a Prolactin-expressing Plasmid into Muscle  

Lee, Jung-Sun (Department of Life Science, The Catholic University of Korea)
Yun, Bo-Young (Department of Life Science, The Catholic University of Korea)
Kim, Sang-Soo (Department of Life Science, Hanyang University)
Cho, Chunghee (Department of Life Science Gwangju Institute of Science and Technology)
Yoon, Yong-Dal (Department of Life Science, Hanyang University)
Cho, Byung-Nam (Department of Life Science, The Catholic University of Korea)
Publication Information
Molecules and Cells / v.22, no.2, 2006 , pp. 189-197 More about this Journal
Abstract
Prolactin (PRL) is a pituitary hormone involved in various physiological processes, including lactation, mammary development, and immune function. To further investigate the in vivo and comparative endocrine roles of PRL, mouse PRL cDNA fused to the cytomegalovirus promoter, was introduced into muscle by direct injection. Previously we studied the function of rat PRL using the same protocol. PRL mRNA was detected in the muscle following injection by RT-PCR and subsequent Southern blot analysis. PRL was also detected and Western blot analysis revealed a relatively high level of serum PRL. In the pCMV-mPRL-injected female mice, the estrous cycle was extended, especially in diestrus stage and the uterus thickening that was shown in normal estrous stage was not observed. In the pCMV-mPRL-injected male mice, new blood vessels were first found at 5 weeks of age and fully developed blood vessels were found after 8 weeks in the testis. The number of Leydig cells increased within the testis and the testosterone level in serum was observed high. Finally, the number of white blood cells (WBCs) increased in the pCMV-mPRL-injected mice. The augmentation of WBCs persisted for at least 20 days after injection. When injection was combined with adrenalectomy, there was an even greater increase in number of WBCs, especially lymphocytes. This increase was returned normal by treatment with dexamethansone. Taken together, our data reveal that intramuscularly expressed mouse PRL influences reproductive functions in female, induces formation of new blood vessels in the testis, and augments WBC numbers. Of notice is that the Leydig cell proliferation with increased testosterone was conspicuously observed in the pCMV-mPRL-injected mice. These results also suggest subtle difference in function of PRL between mouse and rat species.
Keywords
Angiogenesis; Cell Proliferation; Prolactin; Reproductive Function;
Citations & Related Records

Times Cited By Web Of Science : 2  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Bernton, E. W., Meltzer, M. S., and Holaday, J. W. (1988) Suppression of macrophage activation and lymphocyte function in hypoprolactinemic mice. Science 239, 401−404
2 Berry, S. J., Coffey, D. S., Walsh, P. C., and Ewing, L. L. (1984) The development of human benign prostatic hyperplasia with age. J. Urol. 132, 474−479
3 Bole-Feysor, C., Goffin, V., Edery, M., Binart, N., and Kelly, P. A. (1998) Prolactn (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrine Rev. 19, 225−268   DOI   ScienceOn
4 Clevenger, C. V., Altmann, S. W., and Prystowsky, M. B. (1991) Requirement of nuclear prolactin for interleukin-2- stimulated proliferation of T lymphocytes. Science 253, 77−79   DOI
5 Danko, I., Williams, P., Herweijer, H., Zhang, G., Latendresses, J. S., et al. (1997) High expression of naked plasmid DNA in muscles of young rodents. Hum. Mol. Genet. 6, 1453−1443
6 Fletcher-Chiappini, S. E., Comptom, M. M., Lavoie, H. A., Day, E. B., and Witorsch, R. J. (1993) Glucocorticoid-prolactin interactions in Nb2 lymphoma cells: antiproliferative versus anticytolytic effects. Proc. Soc. Exp. Biol. Med. 202, 345− 352
7 Gunasekar, P. G., Kumaran, B., and Govindarajulu, P. (1988) Prolactin and Leydig cell steroidogenic enzymes in the bonnet monkey (macaca radiata). Int. J. Androl. 11, 53−59
8 Harper, M. E., Peeling, W. B., Cowley, T., Brownsey, B. G., Philips, M. E. A., et al. (1976) Plasma steroid and protein hormone concentration in patients with prostatic carcinoma, before and during oestrogen therapy. Acta. Endocrinol. (Copenh) 81, 409−426
9 Kant, G. J., Bauman, R. A., Anderson, S. M., and Mougey, E. H. (1992) Effects of controllable vs. uncontrollable chronic stress on stress-responsive plasma hormones. Physiol. Behav. 51, 1285−1288
10 Leong, D. A., Frawley, L. S., and Neill, J. D. (1983) Neuroendocrine control of prolactin secretion. Ann. Rev. Physiol. 45, 109−127
11 Ormandy, C. J., Camus, A., Barra, J., Damotte, D., Lucas, B., et al. (1997) Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11, 167−178
12 Pellegrini, I., Lebrun, J.-J., Ali, S., and Kelly, P. A. (1992) Expression of prolactin and its receptor in human lymphoid cells. Mol. Endocrinol. 6, 1023−1031   DOI   ScienceOn
13 Russell, D. H., Matrisian, L., Kibler, R., Larson, D. F., Poulos, B., et al. (1984) Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem. Biophys. Res. Commun. 121, 899−906
14 Wennbo, H., Kindblom, J., Isaksson, O. G., and Tornell, J. (1997) Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 138, 4410−4415
15 Witorsch, R. J., Day, E. B., Lavoie, H. A., Hashemi, N., and Taylor, J. K. (1993) Comparison of glucocorticoid-induced effects in prolactin-dependent and autonomous rat Nb2 lymphoma cells. Proc. Soc. Exp. Biol. Med. 203, 454−460
16 Loudon, A. S., Brinklow, B. R., Gulland, F. D., Boyle. J., and Flint, A. P. (1990) Roles of prolactin and the uterus in the control of luteal regression in the Bennetts's wallaby (Macropus rufogriseus rufogriseus). Reprod. Fertil. Dev. 2, 71−78
17 Montgomery, D. W., LeFevre, J. A., Ulrich, E. D., Adamson, C. R., and Zukoski, C. F. (1990) Identification of prolactin-like proteins synthesized by normal murine lymphocytes. Endocrinology 127, 2601−2603   DOI   ScienceOn
18 Walker, A. M., Montgomery, D. W., Saraiya, S., Ho, T. W. C., Garewal, H. S., et al. (1995) Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes. Proc. Natl. Acad. Sci. USA 92, 3278−3282
19 Sinha, Y. N. (1995) Structure variants of prolactin: Occurrence and physiological significance. Endocrine Rev. 16, 354−369
20 Elias, K. A. and Weiner, R. L. (1984) Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc. Natl. Acad. Sci. USA 81, 4549−4553
21 Maurer, R. A. (1982) Estradiol regulates the transcription of the prolactin gene. J. Biol. Chem. 257, 2133−2136
22 Boutin, J.-M., Jolicoeur, C., Okamura, H., Gagnon, J., Edery, M., et al. (1988) Cloning and gene expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53, 69−77   DOI   ScienceOn
23 Clevenger, C. V., Sillman, A. L., Hanley-Hyde, J., and Prystowsky, M. B. (1992) Requirement for prolactin during cell cycle regulated gene expressed in cloned T-lymphocytes. Endocrinology 130, 3216−3222   DOI   ScienceOn
24 Olazabal, I., Munoz, J., Ogueta, S., Obregon, E., and Garcia- Ruiz, J. P. (2000) Prolactin (PRL)-PRL receptor system increases cell proliferation involving JNK (c-Jun amino terminal kinase) and AP-1 activation: Inhibition by glucocorticoids. Mol. Endocrinol. 14, 564？575   DOI   ScienceOn
25 Raymond, V., Beaulieu, M., Labrie, F., and Boissier, J. (1978) Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. Science 200, 1173−1175
26 Bouchard, B., Ormandy, C. J., Di Santo, J. P., and Kelly, P. A. (1999) Immune system development and function in prolactin receptor-deficient mice. J. Immunol. 163, 576−582
27 Nevalainen, M. T., Valve, E. M., Ingelton, P. M., Nurmi, M., Martikainen, P. M., et al. (1997) Prolactin and prolactin receptors are expressed and functioning in the human prostate. J. Clin. Invest. 99, 618−627
28 Steger, R. W., Chandrashekar, V., Zhao, W., Bartke, A., and Horseman, N. D. (1998) Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene. Endocrinology 139, 3691−3695
29 Gala, R. R. and Shevach, E. M. (1997) The immunomodulatory effects of a recombinant bovine prolactin (rbPRL) are secondary to endotoxin contamination. FASEB. J. 11, 99A
30 Jackson, D., Volpert, O. V., Bouck, N., and Linzer, D. I. H. (1994) Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science 266, 1581−1584   DOI
31 Binart, N., Melaine, N., Pineau, C., Kercret, H., Touzalin, A. M., et al. (2003) Male reproductive function is not affected in prolactin receptor-deficient mice. Endocrinology 144, 3779− 3782   DOI   ScienceOn
32 Maurer, R. A. (1980) Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells. J. Biol. Chem. 255, 8092−8097
33 Clevenger, C. V., Chang, W. P., Ngo, W., Pasha, T. L. M., Montone, K. T., et al. (1995) Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am. J. Pathol. 146, 695−705
34 Clapp, C., Martial, J. A., Guzman, R. C., Rentier-Delrue, F., and Weiner, R. I. (1993) The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133, 1292−1299   DOI   ScienceOn
35 Ginsberg, E. and Vonderharr, B. K. (1995) Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 55, 2591−2595
36 Lee, D. W. and Markoff, E. (1986) Synthesis and release of glycosylated prolactin by human deciduas in vitro. J. Clin. Endocrinol. Metab. 62, 990−994
37 Neill, J. (1988) Prolactin secretion and its control; in The Physiology of Reproduction, Knobil, E. and Neill, J. (eds.), pp. 1379−1390, Raven Press, New York
38 Saroff, J., Kirdani, R. Y., Chu, M., Wajsman, Z., and Murhpy, G. P. (1980) Measurements of prolactin and androgens in patients with prostatic diseases. Oncology 37, 46−52
39 Clevenger, C. V., Russell, D. H., Appasamy, P. M., and Prystowsky, M. B. (1990) Regulation of IL2-driven Tlymphocyte proliferation by prolactin. Proc. Natl. Acad. Sci. USA 87, 6460−6464
40 Lee, C. W., Lee, C. U., Kim, J. H., Son, B. C., Kim, D. H., et al. (2003) Effects of Aroclor 1254 on the expression of rat placental PRL-family genes. Mol. Cells 15, 114−121
41 Ferrara, N., Clapp, C., and Weiner, R. (1991) The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129, 896−900
42 Horseman, N. D., Zhao, W., Montecino-Rodriquez, E., Tanaka, M., Nakashima, K., et al. (1997) Defective mammopoiesis, but hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 16, 6926−6935   DOI   ScienceOn
43 Cho, B. N., McMullen, M. L., Pei, L., Yates, C. J., and Mayo, E. K. (2001) Reproductive deficiencies in the transgenic mice expressing the rat inhibin $\alpha$-subunit gene. Endocrinology 142, 4994−5004   DOI   ScienceOn
44 Hammond, G. L., Kontturi, M., Maattala, P., Puukka, M., and Vihko, R. (1977) Serum FSH, LH and prolactin in normal males and patients with prostatic diseases. Clin. Endocrinol. (Oxf) 7, 129−135
45 Struman, I., Bentzien, F., Lee, H., Mainfroid, V., D'Angelo, G., et al. (1999) Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis. Proc. Natl. Acad. Sci. USA 96, 1246− 1251
46 Dombrowicz, D., Sente, B., Closset, J., and Hennen, G. (1992) Dose-dependent effects of human prolactin on the immature hypophysectomized rat testis. Endocrinology 130, 695−700   DOI   ScienceOn
47 Hanahan, D. and Folkman, J. (1996) Pattern and emerging mechanism of the angiogenic switch during tumorigenesis. Cell 86, 353−364
48 Folkman, J. (1995) Angiogenesis inhibitors generated by tumors. Mol. Med. 1, 120−122
49 Ko, J.-Y., Ahn, Y.-L., and Cho, B. N. (2003) Angiogenesis and white blood proliferation induced in mice by injection of a prolactin-expressing plasmid into muscle. Mol. Cells 15, 262−270
50 Matsuyama, S., Shiota, K., and Takahashi, M. (1990) Possible role of transforming growth factor-$\beta$ as a mediator of luteotropic action of prolactin in rat luteal cell cultures. Endocrinology 127, 1561−1567   DOI   ScienceOn